Table 2.
Clinical characteristics of the investigated subjects.
| Clinical features | Total | Percentage |
|---|---|---|
| AAU patients | 929 | 100 |
| Mean age ± SD (years) | 39.8 ± 12.3 | |
| AAU with AS | 443 | 47.7 |
| AAU without AS | 486 | 52.3 |
| AAU male | 569 | 61.2 |
| AAU female | 360 | 38.8 |
| AAU with AS (male) | 326 (443 tested) | 73.6 |
| AAU with AS (female) | 117 (443 tested) | 26.4 |
| AAU without AS (male) | 243 (486 tested) | 50 |
| AAU without AS (female) | 243 (486 tested) | 50 |
| HLA-B27+ AAU | 546 (792 tested) | 68.9 |
| HLA-B27+AAU AS+ | 348 (428 tested) | 81.3 |
| HLA-B27+AAU AS− | 198 (364 tested) | 54.4 |
| Control | 714 | 100 |
| Mean age ± SD (years) | 39.5 ± 10.8 | |
| Male | 428 | 59.9 |
| Female | 286 | 40.1 |